Cafepharma Today

January 24 2024 - Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Moderna races to create norovirus vaccines
Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial
Trump administration delays funding to cancer research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Johnson & Johnson: Lowered Guidance Tamped Down Q4 Earnings Excitement
Seeking Alpha
Thursday, January 22, 2009 - 8:35am
tags:
JNJ, earnings
NicOx Gets New Approaches, Will Hire Bank for Advice
Bloomberg
Thursday, January 22, 2009 - 8:33am
tags:
Wyeth, Sanofi, Pfizer, NicOx, Merck
The FDA's Big Bad Wolfe
Forbes
Wednesday, January 21, 2009 - 9:23pm
tags:
FDA, Sidney Wolfe
King Pharmaceuticals falls after judge overturns 2 patents on muscle relaxant Skelaxin
Yahoo/AP
Wednesday, January 21, 2009 - 5:45pm
tags:
King, Skelaxin, patents, generics
Forest Laboratories shares fall as Wall Street voices concern on product pipeline
Yahoo/AP
Wednesday, January 21, 2009 - 5:43pm
tags:
Forest Labs
A Beaker Full Of Biotech Stocks
CNBC
Wednesday, January 21, 2009 - 4:30pm
tags:
biotech, Millipore, Qiagen
Seattle Genetics, FDA agree on cancer study design
Yahoo/AP
Wednesday, January 21, 2009 - 4:28pm
tags:
Seattle Genetics, FDA, drug trials, cancer
J&J Strong on Fundamentals
Yahoo/Zacks.com
Wednesday, January 21, 2009 - 4:27pm
tags:
JNJ
Abbott Chief Sees ‘Good Time’ to Shop for Deals
Bloomberg
Wednesday, January 21, 2009 - 4:26pm
tags:
Abbott Laboratories, buyouts, Miles White
Are state's pharma gift rules too strict?
Fierce Pharma
Wednesday, January 21, 2009 - 10:46am
tags:
pharma gifts
Genentech could see cancer study results in April
Yahoo/AP
Wednesday, January 21, 2009 - 10:44am
tags:
Genentech, colon cancer, cancer, Avastin
RegeneRx to Shift Ophthalmic Clinical Development Strategy
Yahoo
Wednesday, January 21, 2009 - 10:43am
tags:
RegeneRx, RGN-259
Are More Rent-a-Reps on the Way?
InVivo
Wednesday, January 21, 2009 - 10:42am
tags:
CSO, contract sales, layoffs, Merck, Pfizer, outsourcing
3SBIO Files for Approval on Three New Drugs
Seeking Alpha
Wednesday, January 21, 2009 - 9:37am
tags:
3SBio, TPIAO, ITP, NuLeusin, renal cell carcinoma, EPIAO
Antidepressant Eases Anxiety in Older Adults
Washington Post, DC
Wednesday, January 21, 2009 - 9:35am
tags:
anxiety, elderly, antidepressant, Forest Labs, Lexapro
Diversified Abbott Outshines Diversified Johnson & Johnson
WSJ Online
Wednesday, January 21, 2009 - 9:25am
tags:
Abbott Laboratories, JNJ, earnings
[video]Gurus Buy Drugs, Ditch Disney
Forbes
Wednesday, January 21, 2009 - 9:14am
tags:
Sanofi
Abbott Profit Jumps 28% on Sales of Humira, Xience
Bloomberg
Wednesday, January 21, 2009 - 9:12am
tags:
Abbott Laboratories, earnings, Humira, Xience
King Pharmaceuticals Reports Intent to Appeal SKELAXIN Summary Judgment Order
Yahoo
Wednesday, January 21, 2009 - 7:23am
tags:
Skelaxin, King, Eon Labs, generics
Myriad Pharmaceuticals Acquires Novel HIV Drug, Bevirimat
Yahoo
Wednesday, January 21, 2009 - 6:59am
tags:
HIV, Myriad Genetics, Panacos, bevirimat

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels
2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline
Versatile Chaperones
In the Pipeline

Latest Jobs

Onsite Endoscopic Specialist - Operating Room Support
Santa Monica, California
KARL STORZ Endoscopy - America
Area Manager, Immunology Rochester, NY Territory
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Tarrytown, NY
Tarrytown, New York
Lundbeck
Area Manager Specialty, West- Central
Fields, Oregon, 97710
CSL Behring
Area Sale Manager, Immunology Tampa North
Fields, Oregon, 97710
CSL Behring
Sales Representative
Boise, Idaho, 83708
Bartlett Roofing
Capital Project Manager
Carteret, New Jersey, United States
The Spear Group
Area Manager Specialty, West
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Midland, TX
Midland, Texas, 79701
Lundbeck
Home Health and Medical Sales
The Woodlands, Texas, 77381
Comfort Keepers of Dallas TX
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information